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PCardiac Surgery
Genetic Variants in P-Selectin
and C-Reactive Protein Influence
Susceptibility to Cognitive Decline After Cardiac Surgery
Joseph P. Mathew, MD,* Mihai V. Podgoreanu, MD,* Hilary P. Grocott, MD,*
William D. White, MPH,* Richard W. Morris, PHD,* Mark Stafford-Smith, MD,*
G. Burkhard Mackensen, MD,* Christine S. Rinder, MD, James A. Blumenthal, PHD,†
Debra A. Schwinn, MD,*‡§ Mark F. Newman, MD,* for the PEGASUS Investigative Team
Durham, North Carolina; and New Haven, Connecticut
Objectives We hypothesized that candidate gene polymorphisms in biologic pathways regulating inflammation, cell matrix
adhesion/interaction, coagulation-thrombosis, lipid metabolism, and vascular reactivity are associated with post-
operative cognitive deficit (POCD).
Background Cognitive decline is a common complication of coronary artery bypass graft (CABG) surgery and is associated
with a reduced quality of life.
Methods In a prospective cohort study of 513 patients (86% European American) undergoing CABG surgery with cardio-
pulmonary bypass, a panel of 37 single-nucleotide polymorphisms (SNPs) was genotyped by mass spectrometry.
Association between these SNPs and cognitive deficit at 6 weeks after surgery was tested using multiple logistic
regression accounting for age, level of education, baseline cognition, and population structure. Permutation
analysis was used to account for multiple testing.
Results We found that minor alleles of the CRP 1059G/C SNP (odds ratio [OR] 0.37, 95% confidence interval [CI] 0.16
to 0.78; p  0.013) and the SELP 1087G/A SNP (OR 0.51, 95% CI 0.30 to 0.85; p  0.011) were associated
with a reduction in cognitive deficit in European Americans (n  443). The absolute risk reduction in the observed
incidence of POCD was 20.6% for carriers of the CRP 1059C allele and 15.2% for carriers of the SELP 1087A allele.
Perioperative serum C-reactive protein (CRP) and degree of platelet activation were also significantly lower in patients
with a copy of the minor alleles, providing biologic support for the observed allelic association.
Conclusions The results suggest a contribution of P-selectin and CRP genes in modulating susceptibility to cognitive decline
after cardiac surgery, with potential implications for identifying populations at risk who might benefit from tar-
geted perioperative antiinflammatory strategies. (J Am Coll Cardiol 2007;49:1934–42) © 2007 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.01.080a
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tostoperative cognitive dysfunction (POCD), including im-
airments in attention, memory, language, and processing
ime, serves as a marker of long-term cognitive decline and is
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006, accepted January 9, 2007.ssociated with a reduced quality of life despite patients’
xpectations that recovery of physical status will generally
mprove their lives (1). Although many adverse events related
o cardiac surgery have been minimized, little progress has been
ade in reducing POCD, occurring in as many as 53% of
atients at hospital discharge and 36% at 6 weeks (2). The
tiology of perioperative neurologic injury is multifactorial and
ncludes cerebral embolism and hypoperfusion, but preliminary
eports of heritability of cognitive decline (3,4) suggest that
enetic factors may also modulate response to this type of
eurologic injury. We therefore hypothesized that polymor-
hisms in candidate genes regulating biologic pathways for
nflammation, cell matrix adhesion/interaction, coagulation-
hrombosis, lipid metabolism, and vascular reactivity are asso-
iated with incidence of POCD after CABG surgery.
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tudy population. Patients enrolled in the study were part
f the PEGASUS (Perioperative Genetics and Safety Out-
omes Study), an ongoing Institutional Review Board-
pproved prospective longitudinal study at Duke University
edical Center. The present substudy targeted a cohort of
atients undergoing isolated coronary artery bypass graft
CABG) surgery using cardiopulmonary bypass (CPB)
etween April 1994 and May 2002 in whom detailed
enotyping and prospective cognitive testing were per-
ormed. Patients were excluded if they had a history of
ymptomatic cerebrovascular disease, psychiatric illness, re-
al failure, active liver disease, bleeding disorders, or less
han a seventh-grade education.
easurement of cognitive function phenotype. Cogni-
ive function was assessed the day before surgery and at 6
eeks after surgery by investigators experienced in neuro-
sychologic testing and who were blinded to the genetic
ata. In accordance with the Consensus Statement on
ssessment of Neurobehavioral Outcomes After Cardiac
urgery (5), we used a cognitive test battery comprising the
ollowing 5 instruments: Short Story module of the Randt
emory Test (6), Modified Visual Reproduction Test from
he Wechsler Memory Scale (7), Digit Span subtest of the
echsler Adult Intelligence Scale-Revised (WAIS-R)
xam (8), Digit Symbol subtest of the WAIS-R (8), and the
rail Making Test (Part B) (9).
To account for correlation among cognitive test scores,
e performed factor analysis on the 10 cognitive test scores
rom baseline, as previously described (2). We used SAS
roc Factor (SAS/Genetics version 8.02, SAS Institute,
ary, North Carolina) with a principal components method
ithout priors. Factors were rotated by an orthogonal
arimax transformation yielding uncorrelated rotated factors
nd independent scores representing 4 cognitive domains:
) verbal memory and language comprehension (short-term
nd delayed); 2) attention, psychomotor processing speed,
nd concentration; 3) abstraction and visuospatial orienta-
ion; and 4) figural memory. The factor analysis was
erformed on baseline (preoperative) scores from all eligible
atients in our ongoing prospective post-CABG cognitive
atabase (n  867), of which the patients in the present
tudy were a subset. Factor weights were then used to score
he patients in the present study, both at baseline and at 6
eeks. Postoperative cognitive deficit was defined as a
ecline from baseline score of at least 1 standard deviation
or 1 or more of the 4 domain scores at 6 weeks after
urgery. Baseline cognitive score was defined as the mean
f the 4 preoperative factor scores. A complete description
f the factor analysis, including a scree plot and a table of
actor loadings, is available in the online appendix.
andidate gene and polymorphism selection. A candi-
ate gene set, representing pathways putatively involved in
ognitive dysfunction, was selected a priori based on compre-
ensive analysis of existing expression studies, linkage data, feuropharmacology, population-
ased association studies, and ex-
ert opinion. Principal among
hese are inflammation, cell ma-
rix adhesion/interaction, throm-
osis, lipid metabolism, and
ascular reactivity pathways.
reference was given to genes
reviously implicated in memory,
earning, cognition, or mental re-
ardation in both humans and
xperimental animal models of
ognition (10). A panel of 37
pecific polymorphisms in these
andidate genes was identified
rom public databases, with em-
hasis on variants with demon-
trated or high likelihood of
unctionally significant effects (Table 1).
solation of genomic DNA and genotype analysis. After
solation of genomic DNA from whole blood, genotyping
ssays were conducted by matrix assisted laser desorption/
onization time-of-flight mass spectrometry on a Sequenom
assArray system (Sequenom, San Diego, California) at
gencourt Bioscience Corporation (Beverly, Massachu-
etts). Primers used and polymorphism details are available
t: http://anesthesia.duhs.duke.edu/pegasus/cognition/1/
ognition-webTable1.htm. Genotyping accuracy of the
equenom MassArray system was estimated at 99.6% (11).
sing direct sequencing on an ABI3700 capillary sequencer
Applied Biosystems, Foster City, California), genotyping
eproducibility in this study was validated to be 99% by
coring a panel of 6 polymorphisms in 100 randomly
elected patients. The ACE insertion/deletion polymor-
hism was genotyped by polymerase chain reaction ampli-
cation followed by size-fractionation through electro-
horesis (12).
tatistical analysis. Categoric and continuous demo-
raphic characteristics were compared between POCD
roups with Pearson chi-squared and Wilcoxon rank sum
ests, respectively. To test for association between the 37
andidate gene polymorphisms and incidence of POCD, we
sed a previously described 2-stage analysis approach:
arker selection by set association followed by model
uilding (13). This method has been shown to be much
ore powerful than individual marker analysis when mul-
iple genes are likely involved in a disease phenotype (14).
Allele and genotype frequencies were calculated for each
olymorphism, and Hardy-Weinberg equilibrium was eval-
ated using an exact test. All association analyses were based
n 2 genotypic classes, distinguished by the presence or
bsence of at least 1 copy of the minor allele (homozygote
inor and heterozygote versus homozygote major). In the
rst stage, the set association approach (15) was used to
dentify a set of markers jointly associated with POCD as
Abbreviations
and Acronyms
AA  African American
CABG  coronary artery
bypass graft
CD62P  P-selectin
CPB  cardiopulmonary
bypass
CRP  C-reactive protein
EA  European American
NA  Native American
POCD  postoperative
cognitive deficit
SELP  P-selectin gene
SNP  single-nucleotide
polymorphismollows: Pearson’s chi-square statistics were computed for
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Genetics of Postoperative Cognitive Decline May 15, 2007:1934–42ach of the 37 polymorphisms and ordered from largest to
mallest (1  2  . . . 37); sums (si; i  1, 2, . . . , 10)
ere formed from the 10 largest single-locus statistics; the
mpirical significance level pi associated with each si was
valuated based on 3,000 random permutations of the data
et; the set of markers associated with the smallest pi was
elected for further analysis. A series of logistic regression
odels was then developed to test for association between
ach pair of markers in the selected set (both as main effects
nd in interaction) and POCD. Model p values were
onferroni corrected for multiple comparisons.
To account for covariable effects and population substruc-
ure, self-reported ethnicity, age, baseline cognitive score, and
ears of education were subsequently included in multiple
olymorphisms Evaluated for Their Relationship to Cognitive Declin
Table 1 Polymorphisms Evaluated for Their Relationship to Cog
Functional Category Gene Name SNP ID
Inflammation CRP (C-reactive protein) rs1205
rs180094
IL1A (interleukin-1 alpha) rs17561†
rs180058
IL1RN (interleukin-1 receptor antagonist) rs315952
rs222923
IL6 (interleukin-6) rs180079
rs180079
rs180079
TNFA (tumor necrosis factor-alpha) rs180061
rs180062
rs180075
rs361525
Cell matrix adhesion/
interaction
MMP3 (matrix metalloproteinase-3) rs302505
MMP9 (matrix metalloproteinase-9) rs391824
SELP (P-selectin) rs180080
rs6131
rs6127
rs6133
rs6136
Coagulation-thrombosis GP1BA (glycoprotein Ib alpha) rs224309
rs6065
GP6 (glycoprotein VI) rs161366
ITGA2 (glycoprotein IaIIa) rs112664
rs28095
ITGB3 (glycoprotein IIIa) rs5918
PAI1 (plasminogen activator inhibitor 1) rs179976
rs222763
Lipid metabolism APOE (apolipoprotein E) rs405509
rs429358
rs7412
Vascular reactivity ACE (angiotensin-converting enzyme) rs4291
rs4344
SNP030
NOS3 (endothelial nitric oxide synthase) rs179998
rs179998
rs207074
From NCBI’s dbSNP public database: http://www.ncbi.nlm.nih.gov/SNP/. †Formerly rs1799942
CABG  coronary artery bypass graft; D  deletion allele; EA  European American; I  insertogistic regression modeling. Interactions between genotype end these covariates were also tested. Patients representing
thnic groups other than European American (EA), African
merican (AA), and Native American (NA) were excluded
rom analyses involving race. Furthermore, the structured
ssociation method was used to control for the possibility of
ryptic heterogeneity within the EA patients (16,17); multilo-
us genotypes from a panel of 52 unlinked bi-allelic null
arkers, evenly distributed across the genome, were analyzed
sing Structure version 2.1 software (Division of Biological
ciences, University of Chicago, Chicago, Illinois) to identify
lusters of genetically similar individuals. Posterior probabilities
f subpopulation membership (based on 2 putative subpopu-
ations) were subsequently used in the logistic regression
odels that included age, baseline cognitive score, and years of
er CABG Surgery
e Decline After CABG Surgery
Major/Minor Allele
Genomic
Context
Minor Allele Frequency in EA Patients
Without Cognitive Deficit
2147C/T 3=UTR 0.338
1059G/C L184L 0.080
10876G/T A114S 0.315
889 C/T 5=UTR 0.317
16857T/C S112S 0.302
13760T/C A39A 0.297
174G/C 5=UTR 0.473
572G/C 5=UTR 0.044
597G/A 5=UTR 0.469
1078G/A intron 0.075
308G/A 5=UTR 0.153
376G/A 5=UTR 0.009
238G/A 5=UTR 0.070
1171 indel (5A/6A) 5=UTR 0.500
1562C/T 5=UTR 0.119
1969A/G 5=UTR 0.412
1087G/A S331N 0.183
1902A/G N603D 0.391
2013G/T V640L 0.117
2361A/C T756P 0.117
5 T/C 5=UTR 0.102
2217C/T T161M 0.075
13254T/C S219P 0.186
64448C/T F253F 0.357
52C/T 5=UTR 0.346
1565T/C L59P 0.167
675 indel (5G/4G) 5=UTR 0.459
844A/G 5=UTR 0.428
219G/T 5=UTR 0.475
448T/C C130R 0.125
586C/T R176C 0.071
240A/T 5=UTR 0.405
2350G/A intron 0.421
(in 16) indel (D/I) intron 0.416
894G/T E298D 0.318
10(in23)G/T intron 0.307
786T/C 5=UTR 0.356
erly rs2229234. §Formerly rs1800198. Duke polymorphism ID number.
le; SNP  single-nucleotide polymorphism; UTR  untranslated region.e Aft
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sing Phase version 2.0 software (Department of Statistics,
niversity of Washington, Seattle, Washington) (18); sub-
equent haplotype analyses were carried out using Hap-
o.stats software (Division of Biostatistics, Mayo Clinic,
ochester, Minnesota) (19), restricted to haplotypes with an
nferred frequency of 1%. All statistical analyses were
erformed using SAS and SAS/Genetics version 8.02 (SAS
nstitute).
echanistic subset analyses. Based on positive genetic
ssociations, platelet activation was measured in a subset of
3 patients for whom serial arterial blood samples had been
ollected before induction of anesthesia, before aortic cross-
lamp release, 10 min after cross-clamp release, at end of
PB, and at end of surgery. After incubation with saturat-
ng concentrations of monoclonal antibodies, blood samples
ere analyzed on a FACScan flow cytometer (Becton-
ickinson, Mountain View, California). The percentage of
latelets expressing P-selectin (CD62P) was determined as
marker of platelet activation. Similarly, C-reactive protein
CRP) levels were serially measured in a subset of 239
atients from whom serum had been collected before
nduction of anesthesia and at 4.5, 24, and 48 h after
ross-clamp removal. Immunoassays were forward immu-
ometric assays performed by Biosite Diagnostics (San
emographic Characteristics of the Study Population
Table 2 Demographic Characteristics of the Study Population
All Patients,
n  677
Cognitive De
No, n  330
Age (yrs) 61.7 (10.5) 60.7 (10.3)
Height (cm) 171.5 (10.2) 171.6 (10.5)
Weight (kg) 86.2 (17.9) 85.9 (17.9)
Ejection fraction (%) 54.1 (12.2) 54.2 (11.7)
CPB time (min) 109.7 (36.7) 107.9 (33.7)
Cross-clamp time (min) 58.2 (23.6) 57 (23.4)
No. of grafts 3.2 (0.9) 3.1 (0.9)
Years of education 12.4 (3.2) 12.4 (3.2)
Baseline cognitive score 0.003 (0.516) 0.01 (0.488)
Female gender (%) 30.4 30.6
Prior CABG (%) 3.1 3.3
Prior MI (%) 29.1 28.0
Prior stroke/TIA (%) 2.1 1.3
Unstable angina (%) 60.4 57.6
Diabetes (%) 30.2 26.5
CHF (%) 11.9 10.4
Hypertension (%) 62.8 61.8
COPD (%) 9.4 9.4
PVD (%) 12.4 12.3
Race
European American (%) 86.0 88.2
African American (%) 9.7 8.5
Native American (%) 3.7 3.0
Other (%) 0.6 0.3
alues are expressed as mean (SD) or as %. *Nonreturn group: deceased (13), incomplete testing
CogDef group p values compare patients with and without cognitive deficit. ‡Return group p val
CABG  coronary artery bypass graft; CHF  congestive heart failure; CogDef  cognitive deficit; COP
nfarction; PVD  peripheral vascular disease; TIA  transient ischemic attack.iego, California) in 384-well microtiter plates using a
ecan Genesis RSP 200/8 Workstation (Tecan, Research
riangle Park, North Carolina).
The association between percentage of P-selectin–
ositive platelets and SELP genotype and between serum
RP levels and CRP genotype was tested using repeated
easures analysis of variance (ANOVA) based on log
ransformation and using an unstructured covariance model.
ecause baseline concentrations differed between SELP
enotypes, concentration levels at subsequent times were
xpressed as ratio to baseline. Genotype differences at
ndividual event times were tested using Wilcoxon rank sum
ests when analysis of variance was significant at p  0.05.
esults
emographic characteristics of the 677 enrolled patients are
resented in Table 2. Of these, 164 (24%) did not complete
-week testing, leaving 513 patients for the final analyses;
onreturners had a lower educational level and total CPB
ime, were older, and were more likely to suffer from
iabetes and pulmonary and vascular disease. Allele fre-
uencies for the single-nucleotide polymorphisms (SNPs)
dentified below were not different between those who did
nd did not return for 6-week testing. The incidence of
No 6 Week Test,*
n  164
CogDef Group
p Value†
Return Group
p Value‡ 183
(10.5) 64.2 (10.3) 0.740 0.001
(9.5) 170.5 (10.4) 0.837 0.226
(17.8) 85 (18) 0.484 0.188
(11.9) 52.4 (13.4) 0.377 0.092
(29.6) 118.5 (47.2) 0.528 0.003
(20.2) 64.2 (26.3) 0.476 0.001
(0.9) 3.3 (0.8) 0.731 0.172
(3.1) 11.8 (3.2) 0.148 0.006
(0.457) 0.193 (0.562) 0.001 0.001
6.8 34.1 0.365 0.243
2.2 3.7 0.589 0.796
1.9 40.1 0.155 0.001
1.2 4.7 0.999 0.017
5.9 59.7 0.081 0.924
9.1 39.0 0.536 0.007
3.9 12.8 0.300 0.772
1.8 65.8 0.999 0.438
4.6 14.8 0.074 0.011
8.1 17.4 0.171 0.034
0.153 0.394
3.1 84.8
9.8 12.2
5.5 3.0
1.6 0.0
r health (31), unable to travel (17), unwilling to return (43), unable to contact (38), or other (19).
pare patients with and without 6-week cognitive tests.ficit
Yes, n
61.1
172.2
87.8
55.3
105.2
55.1
3.1
12.8
0.179
2
2
6
2
1
6
8
(3), poo
ues comD  chronic obstructive pulmonary disease; CPB  cardiopulmonary bypass; MI  myocardial
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Genetics of Postoperative Cognitive Decline May 15, 2007:1934–42OCD in the study sample was 35.7% (183 out of 513), and
atients with a deficit were similar to those without a deficit
ith the exception of baseline cognition (Table 2).
Initial demographic comparisons revealed differences in
ognitive deficit among racial groups (EA 34.3%, AA
9.1%, NA 50%) after accounting for age, baseline cogni-
ion, and years of education in multivariable logistic regres-
ion. Therefore, all subsequent analyses were limited to the
ubset of EA patients (n  443). Minor allele frequencies
or the 37 polymorphisms examined among the EA patients
ithout cognitive deficit are presented in Table 1. Four
olymorphisms had deviations from Hardy-Weinberg equi-
ibrium and were excluded from subsequent analyses.
The marker selection process identified 5 SNPs whose
um of chi-square statistics had a minimum p value of
.121. Genotype frequencies for these 5 SNPs in patients
ith and without POCD are presented in Table 3. All 10
ossible pairs of 5 SNPs were subjected to logistic regression
nalysis for association with POCD. The smallest
onferroni-corrected model p value (p  0.002) among
odels with main effects only occurred for SNPs CRP
059G/C and SELP 1087G/A. This pair of SNPs also had
he smallest Bonferroni-corrected model p value (p 
.005) among models including both main and interaction
ffects. The interaction effect, however, was not significant
p  0.425).
Logistic regression in EAs identified age, baseline cog-
ition, and years of education in addition to SNPs CRP
059G/C and SELP 1087G/A to be significantly associated
ith POCD (model p  0.0001) (Table 4). No interaction
as found between the SNPs and covariates. Presence of the
inor allele at both CRP and SELP polymorphisms had a
rotective effect; the incidence of cognitive deficit was
6.7% in carriers of minor alleles at both of these loci
enotype Frequencies in European Americansn  443) for 5 SNPs Selected for Pair-Wise Modeling
Table 3 Genotype Frequencies in European Americans(n  443) for 5 SNPs Selected for Pair-Wise Modeling
SNP ID Genotype
Frequency In EAs
With Cognitive
Deficit
Without Cognitive
Deficit
rs361525 A/A 0.000 0.004
TNFA A/G 0.064 0.132
238G/A G/G 0.936 0.864
rs1800797 A/A 0.127 0.188
IL6 A/G 0.530 0.563
597G/A G/G 0.343 0.249
rs1800947 C/C 0.007 0.004
CRP C/G 0.075 0.153
1059G/C G/G 0.918 0.844
rs6131 A/A 0.035 0.034
SELP A/G 0.167 0.298
1087G/A G/G 0.799 0.668
rs1205 C/C 0.518 0.414
CRP C/T 0.447 0.494
2147C/T T/T 0.035 0.091RP C-reactive protein; IL interleukin; SELP P-selectin; TNFA tumor necrosis factor-alpha;
ther abbreviations as in Table 1.ompared with 42.9% in patients homozygous for the major
llele (Fig. 1). Moreover, the absolute risk reduction in the
bserved incidence of POCD was 20.6% for carriers of the
RP 1059C allele and 15.2% for carriers of the SELP
087A allele. The CRP and SELP SNPs were not associ-
ted with baseline cognition. Detailed analyses of cognitive
esponses separately by factor and genotype are available in
he online appendix and at: http://anesthesia.duhs.duke.edu/
egasus/cognition/1/cognition-webAppendix.htm.
Pairwise estimates of linkage disequilibrium in EAs
etween 2 CRP, among 5 SELP SNPs, and between the
RP and SELP SNPs were low, suggesting no strong
orrelation between the POCD-associated SNPs and other
enotyped SNPs. For the CRP gene, containing 2 exons and
intron spanning 7 kb, SNPs 1059G/C and 2147C/T
xhibited r2 0.121 (p 0.001). For the larger SELP gene,
ontaining 17 exons and 16 introns and spanning 50 kb,
2 values between the POCD-associated SNP 1087G/A,
nd SNPs 1969A/G, 1902A/G, 2013G/T, and 2361A/C
ere 0.019, 0.011, 0.019, and 0.008, respectively, with the
rst and third r2 values significant at p  0.01. Sixteen
nique SELP haplotypes were inferred from the 5 common
ELP SNPs, of which 10 exhibited frequencies of 1%.
redictors of Cognitive Deficit After Cardiac Surgeryn European Americans (n  443; Are Under theeceiver-Operating Characteristic Curve for Thiso el Was 0.70)
Table 4
Predictors of Cognitive Deficit After Cardiac Surgery
in European Americans (n  443; Area Under the
Receiver-Operating Characteristic Curve for This
Model Was 0.70)
Variable
Odds
Ratio
95% Confidence
Interval p Value
CRP 1059G/C SNP 0.37 0.16–0.78 0.013
SELP 1087G/A SNP 0.51 0.30–0.85 0.011
Years of education 0.90 0.83–0.98 0.021
Age (per yr) 1.03 1.01–1.06 0.013
Baseline cognitive score 5.71 2.98–11.31 0.001
bbreviations as in Tables 1 and 3.
Figure 1 Incidence of Postoperative Cognitive Deficit
by CRP 1059G/C and SELP 1087G/A Genotypes
The incidence of cognitive deficit was 16.7% in carriers of minor alleles at both
of these loci compared with 42.9% in patients homozygous for the major allele.
CRP  C-reactive protein; SELP  P-selectin. n  386.
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ere significant for 2 haplotypes, each bearing the A allele
f SELP 1087G/A. These haplotypes had frequencies below
% and add little to the observed association of SELP
087G/A to POCD (data not shown).
In separate logistic regression models that included self-
eported race in the entire sample, or subpopulation mem-
ership probabilities in EAs only, the SNP effects remained
ignificant. However, none of the 2-way interactions be-
ween CRP and SELP SNPs with race or subpopulation
embership was significant, suggesting that race and pop-
lation substructure had no effect on the SNP associations
escribed. In non-EAs, the effects of the CRP and SELP
NPs trended toward being protective but were not statis-
ically significant.
For serum CRP levels, a significant interaction between
ime and CRP 1059G/C genotype was seen (p  0.011).
erum CRP levels were significantly lower at the 24-hour
ampling time in patients homozygous (CC) or heterozy-
ous (CG) for the minor allele compared with patients
omozygous (GG) for the major allele (p  0.001) (Fig. 2).
imilarly, a significant genotype and time difference was
een when the effect of the SELP 1087G/A genotype on the
ercentage of P-selectin–positive platelets was examined.
latelet activation was significantly lower upon release of the
ross-clamp (p  0.043) (Fig. 3) in patients homozygous
A/A) or heterozygous (G/A) for the minor allele compared
ith patients homozygous (G/G) for the major allele.
iscussion
ognitive dysfunction remains a frequent complication after
ardiac surgery, occurring in approximately 36% of patients
t 6 weeks after surgery. In the present study of 513 CABG
Figure 2 Median CRP Levels by CRP 1059G/C Genotypes
C-reactive protein (CRP) levels at the 24-h sampling time in patients homozy-
gous (C/C) or heterozygous (C/G) for the minor allele were lower compared
with patients homozygous (G/G) for the major allele. n  225. *p  0.05.watients tested with a detailed cognitive test battery before
nd after surgery, we report a potential genetic basis for this
ognitive decline. In addition to the previously described
isk factors of age, level of education and baseline cognition,
e found that the risk of POCD was significantly lower in
atients carrying at least 1 copy of the CRP 1059C or SELP
087A alleles, with an additive effect between loci. Further-
ore, we provide preliminary evidence that perioperative
erum levels of CRP and platelet activation were reduced in
atients with these polymorphisms, providing biologic un-
erpinning to the observed allelic association.
Coronary artery bypass graft surgery using CPB is asso-
iated with ischemia-reperfusion injury, inducing a complex
nflammatory response that impacts not only the heart but
lso the brain, lungs, kidneys, and gut (20). C-Reactive
rotein is an acute-phase reactant produced primarily in the
iver in response to tissue injury or inflammation, implicated
ot only as a marker, but also a potential participant in the
athogenesis of inflammatory-mediated processes (21).
ean CRP concentrations have been reported to rise as
uch as 83-fold from the preoperative period to 72 h after
ABG surgery, and variation in the extent of increase
ppears to be influenced by CRP genotype (22). Recently,
he relationship of patterns of SNP variation at the CRP
ocus to plasma CRP levels has been extensively character-
zed in both EA and AA populations (23,24). The synon-
mous 1059G/C in exon 2 (L184L) has been associated
ith lower CRP levels in several studies (25–27). Zee and
idker (26) reported significantly lower CRP levels in G/C
eterozygotes than in G/G homozygotes (1.05 vs. 1.38
g/l); Suk et al. (25) found a 29% lower baseline CRP level
n carriers of the minor allele at 1059. Furthermore,
059G/C is the only SNP that tags a haplotype associated
Figure 3 Median Platelet Activation
(Relative to Baseline) by SELP 1087G/A Genotypes
Platelet activation was significantly lower upon release of the cross-clamp in
patients with the homozygous minor (A/A) or heterozygous (G/A) genotype com-
pared with patients homozygous (G/G) for the major allele. CPB  cardiopul-
monary bypass; SELP  P-selectin. n  93. *p  0.05.ith the lowest plasma CRP levels; in a large population
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g/l/copy (23). Therefore, it is likely that this polymor-
hism directly influences CRP levels, although the mecha-
ism for a direct effect remains unclear.
The immune system and the central nervous system form
bidirectional communication network. Host defense
gainst infection and recovery from tissue injury includes
ot only immune activation, but also an integrated neuroen-
ocrine response coordinated by the central nervous system,
nd several proinflammatory cytokines have been identified
s the signaling molecules for immune-to-brain communi-
ation (28). In a double-blind crossover study of 20 healthy
ale volunteers given an intravenous injection of endotoxin,
ignificant positive correlations were found between cyto-
ine secretion and endotoxin-induced decreased verbal and
onverbal memory functions (29). These findings are con-
istent with reports that memory impairment is a common
dverse effect of cytokine therapy and viral infection (30,31).
nflammatory mechanisms and immune activation have
een hypothesized to play a role not only in neurodegen-
rative conditions such as Alzheimer’s disease (32) and
ascular dementia (33) but also in age-associated cognitive
ecline (34–36). Yaffe et al. (36) followed 3,031 well-
unctioning subjects for 2 years and reported that a high
aseline level of serum markers of inflammation, most
otably CRP, was associated with poor cognitive perfor-
ance and greater risk of cognitive decline over the
ollow-up period. Similar associations between elevated
aseline CRP levels and greater cognitive decline have been
eported in patients followed for 5 to 6 years (34,35). In the
resent study, the lower incidence of POCD in patients
ith the CRP 1059G/C polymorphism may be related to a
esser degree of perioperative inflammation as evidenced by
he lower levels of serum CRP.
P-selectin (CD62P) is a membrane glycoprotein that is
apidly mobilized to the surface of activated platelets and
ndothelial cells where it mediates leukocyte-platelet and
eukocyte-vascular endothelial cell adhesion, respectively.
oreover, P-selectin expression on activated platelets ap-
ears important for the formation of large stable platelet
ggregates and amplification of leukocyte recruitment pro-
ess (37) and may prime monocytes for tissue factor and
ytokine up-regulation (38). In the setting of CPB, activa-
ion of platelets, as measured by CD62P expression, peaks 2
o 4 h after CPB and returns to baseline 18 hours after CPB
39). Through increased platelet CD62P expression, CPB
esults in formation of monocyte-platelet and, to a lesser
xtent, neutrophil-platelet conjugates (40).
The gene coding for P-selectin (SELP) has been reported
o be highly polymorphic (41). The SELP 1087G/A SNP
esults in a nonsynonymous amino acid change (S290N) in
he consensus repeat (sushi) domain; this extracellular do-
ain has been shown to be important for P-selectin binding
o its ligand on leukocytes (42,43). In a study of 582 subjects
ith myocardial infarction (MI) and 630 age-matchedontrol subjects, Tregouet et al. (44) reported that the risk aor MI associated with the SELP 1087G/A SNP was
educed but differed according to the haplotype background.
n the present study of cardiac surgical patients, we found
he 1087G/A variant to be associated with POCD in both
enotype and haplotype analyses and provide preliminary
vidence for association with lower levels of platelet activa-
ion during CPB. Although several studies revealed associ-
tions between SELP polymorphisms and soluble P-selectin
evels (45,46), which appear highly heritable (47), to our
nowledge this is the first report of an association between
ELP genotype and P-selectin expression on circulating
latelets. However, based on this preliminary data, we
annot rule out that 1087G/A results in altered stability of
embrane-bound P-selectin or differential binding of anti-
odies used for flow cytometry, and further functional
haracterization of this SNP is required.
When interpreting positive findings from any genetic
ssociation study, several epidemiologic limitations should
e considered, including inadequate sample size, poorly
atched control groups, subgroup analyses, multiple test-
ng, and population stratification (48). With regard to these
oncerns, strengths of our study include a relatively large
ample of cardiac surgery patients (n  513) who have
ndergone intensive cognitive evaluation and a prospec-
ive cohort design that reduces the selection bias inherent
n case-control designs. Although serum CRP and plate-
et CD62P data were available only for a subset of patients,
e were able to provide preliminary evidence of a genotypic
ffect on both CRP level and platelet activation. However,
t is possible that the CRP 1059G/C and SELP 1087G/A
NPs are in linkage disequilibrium with other regulatory
causal) variants not within regions previously scanned for
olymorphisms and therefore not included in this study.
his is particularly true for the CRP SNP which is silent at
he amino acid level. Further, our structured association
nalysis revealed no evidence of population stratification in
hese data. Although we did find differences in cognitive
eficit among racial groups, we could not detect a genetic
ffect that differed between races. It is possible that a larger
ample of patients with varying ethnicity may have demon-
trated such an effect. The definition of “significant” cogni-
ive change, although commonly used, also remains contro-
ersial. Our primary aim was to investigate the role of
enetic variability in overall postoperative cognitive function
ather than specific brain functions and independent con-
tructs. Post hoc analyses using individual factor scores as
ell as the raw test scores found no significant associations
etween the CRP and SELP polymorphisms and individual
ognitive domains, which may only mean that genetic
ariations in perioperative inflammatory responses have a
road impact on cortical and subcortical function. Evalua-
ion of other SNPs specifically involved in memory and
earning may, however, yield a domain-specific effect.
In summary, using a prospective cohort study design, we
ound 2 candidate gene polymorphisms with additive effects
ssociated with a reduction in the incidence of cognitive
d
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May 15, 2007:1934–42 Genetics of Postoperative Cognitive Declineecline after cardiac surgery. Functionally, these CRP and
ELP polymorphisms were associated with reductions in
erum CRP and platelet activation, respectively, raising the
ossibility that therapies aimed at reducing the perioperative
nflammatory state may be beneficial. Moreover, using
ardiac surgery as a model of neurologic injury, these results
rovide insight into the biologic factors modulating cogni-
ive performance in humans and further evidence for a
enetic basis of cognitive deterioration, which should trans-
ate into more precise identification of patients at risk.
eprint requests and correspondence: Dr. Joseph P. Mathew,
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APPENDIX
or a list of the members of the PEGASUS Investigative Team, and a
omplete description of the factor analysis, including a scree plot and a
able of factor loadings, please see the online version of this article.
